Futurity August 29, 2024
People with multiple sclerosis are far less likely than those without the condition to have the molecular hallmarks of Alzheimer’s disease, according to new research.
The discovery suggests a new avenue of research through which to seek Alzheimer’s treatments, says Matthew Brier, an assistant professor of neurology and of radiology at Washington University School of Medicine in St. Louis and the study’s first author.
“Our findings imply that some component of the biology of multiple sclerosis (MS), or the genetics of MS patients, is protective against Alzheimer’s disease,” Brier says. “If we could identify what aspect is protective and apply it in a controlled way, that could inform therapeutic strategies for Alzheimer’s disease.”
A collaboration between experts in Alzheimer’s and...
Today's Sponsors
Today's Sponsor